Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

QALSODY 100 MG SOLUCIÓN INYECTABLE - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/QALSODY 100 MG SOLUCIÓN INYECTABLE

Approved

STANDARD

QALSODY 100 MG SOLUCIÓN INYECTABLE

Biogen Netherlands B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jun 14, 2024
Approval ID: 0189eefff3cca073
Company: Biogen Netherlands B.V.
Type: Standard

Approval Details

Approval Id: 0189eefff3cca073
Drug Cima Aemps Name: QALSODY 100 MG SOLUCIÓN INYECTABLE
Register Number: 1231783001
Holder Company Name: Biogen Netherlands B.V.
Marketing Company Name: Biogen Spain S.L.
Holder Company Detail Path: /organization/biogen-netherlands-bv
Authorization Date: 2024-06-14
Dosage Form: SOLUCIÓN INYECTABLE
Dose: 100 mg
Route Of Administration: VÍA INTRATECAL
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Biogen Netherlands B.V.
Company Detail Path: /organization/biogen-netherlands-bv

Company Information

Pharmaceutical Company Name: Biogen Netherlands BV
Country Name: Netherlands
Website: http://www.biogen.nl

Active Ingredients

TOFERSEN

100 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 14, 2024

Approval ID

0189eefff3cca073

Type

Standard

Back to CIMA-AEMPS Approvals